Event Brief
Jul 20, 2026 at 1:07 AM ET
US FDA approves oral PCSK9 inhibitor tablet
By The BriefBrief
The US FDA approved an oral PCSK9 inhibitor as a once-daily alternative to injections for high cholesterol.
WHO: US FDA
WHAT: Approved the first oral PCSK9 inhibitor for managing high cholesterol in adults
WHEN: Jul 20, 2026 at 12:37 AM ET
WHERE: USA
WHY: The FDA gave approval for the once-daily oral PCSK9 inhibitor alternative to injections.
Reporting from 1 identified publisher for this event.
View all 1 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
UN warns terrorists in Nigeria use drones and crypto
United Nations
Jul 20, 2026 at 2:08 AM ET
Court grants bail to Rayann El Houli
World
Jul 20, 2026 at 2:08 AM ET
FBI shifts immigration agent cases to HSI after shootings
Fbi
Jul 20, 2026 at 2:00 AM ET
Trump says Iran strikes were carried out in honour
Donald Trump
Jul 20, 2026 at 1:52 AM ET
Page 12462 of 21458
Same format. Every time.
Continue reading — sign in or create a free account with
